IRIS
VESPASIANI GENTILUCCI, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.770
NA - Nord America 1.115
EU - Europa 610
OC - Oceania 25
AF - Africa 18
SA - Sud America 13
Totale 9.551
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 6.606
US - Stati Uniti d'America 1.075
HK - Hong Kong 657
CN - Cina 409
GB - Regno Unito 170
IT - Italia 159
DE - Germania 111
IN - India 40
FI - Finlandia 35
NL - Olanda 33
CA - Canada 31
CZ - Repubblica Ceca 28
AU - Australia 24
TR - Turchia 20
UA - Ucraina 16
FR - Francia 14
PL - Polonia 13
JP - Giappone 11
ZA - Sudafrica 10
BR - Brasile 8
ES - Italia 7
MX - Messico 6
SE - Svezia 5
ET - Etiopia 4
ID - Indonesia 4
SA - Arabia Saudita 4
BD - Bangladesh 3
CH - Svizzera 3
CL - Cile 3
IR - Iran 3
MA - Marocco 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BE - Belgio 2
KR - Corea 2
KZ - Kazakistan 2
PA - Panama 2
PH - Filippine 2
RU - Federazione Russa 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 9.551
Salva come PNG Salva come JPEG
Città #
Hong Kong 648
Singapore 376
Ashburn 275
Boardman 216
Hefei 197
London 151
Shanghai 134
Rome 70
Munich 62
San Francisco 39
Los Angeles 38
Council Bluffs 37
Seattle 30
Brno 28
Pune 26
West Jordan 22
Santa Clara 20
Turku 20
Amsterdam 18
Toronto 17
Washington 17
Helsinki 15
New York 15
Canberra 12
Warsaw 12
Sona 11
Tokyo 10
Guangzhou 8
Melbourne 7
Montreal 7
Chicago 6
Redmond 6
São Paulo 6
Brooklyn 5
Milan 5
Paris 5
Stockholm 5
Sydney 5
Central 4
Frankfurt am Main 4
Johannesburg 4
Naples 4
The Dalles 4
Zhengzhou 4
Addis Ababa 3
Bari 3
Bologna 3
Boston 3
Brownsville 3
Camden 3
Charlotte 3
Chennai 3
Haikou 3
Kyiv 3
Mexico City 3
Rabat 3
Riyadh 3
Secaucus 3
Valsamoggia 3
Anderlecht 2
Andover 2
Ankara 2
Atlanta 2
Berlin 2
Boydton 2
Buffalo 2
Cervignano del Friuli 2
Cinisello Balsamo 2
Dallas 2
Delhi 2
Falls Church 2
Ferrara di Monte Baldo 2
Foligno 2
Handan 2
Hangzhou 2
Hanover 2
Houston 2
Kharkiv 2
Las Vegas 2
Liverpool 2
Manchester 2
Messina 2
Minneapolis 2
Newark 2
Perugia 2
Rovereto 2
Salt Lake City 2
Shenzhen 2
Shijiazhuang 2
Suzhou 2
Tianjin 2
Torino 2
Vienna 2
Xingtai 2
Zurich 2
Almere Stad 1
Augusta 1
Basingstoke 1
Beijing 1
Bengaluru 1
Totale 2.727
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 209
Advances in management of periprosthetic joint infections: an historical prospective study 197
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 193
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 193
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 190
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 189
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 188
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 185
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 183
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 183
Factors enhancing treatment of hepatitis C virus⇓infected italian people who use drugs: The CLEO-GRECAS experience 183
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 182
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 182
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 180
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 179
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 179
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 178
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 178
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 173
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 173
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 170
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 170
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 170
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 168
Assessment of liver function by the exhaled breath-print during chronic liver disease 166
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 123
GH-resistance in different stages of chronic liver disease 96
Diabetes in chronic liver disease: from old concepts to new evidence 95
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 95
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 94
[A 73-year-old woman with vomiting and metabolic alkalosis] 91
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 90
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 89
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 86
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 83
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 82
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 82
A challenging alfa-fetoprotein in a cirrhotic patient 80
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 79
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 79
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 77
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 75
[A 61-year-old woman with abdominal pain and urination disorders] 75
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 75
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 75
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 75
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 75
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 73
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 72
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 69
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 67
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 65
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 62
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 60
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 59
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement 56
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 56
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 54
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 51
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 43
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 31
TNF-alpha and growth hormone resistance in patients with chronic liver disease 30
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 29
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 28
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 28
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma 27
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. 27
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 27
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 26
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 26
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 26
The pharmacological treatment of chronic comorbidities in COPD: mind the gap! 26
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 25
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 25
The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen 25
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b 24
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 24
Reply 23
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 23
Reelin expression in human liver of patients with chronic hepatitis C infection 23
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 23
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 22
Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension 22
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 22
Renal impairment and anemia during triple therapy 22
Co-infezione HCV-HIV: una nuova sfida clinica [HIV-HCV coinfection: a new clinical challenge] 22
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 22
SINDROME DI SJÖGREN (SS) ASSOCIATA A MALATTIA INFIAMMATORIA PELVICA (PID): DESCRIZIONE DI UN CASO CLINICO 22
Hepatic matrix metalloproteinase-10 exerts a hepatoprotective role after acute liver inury 22
Raised C-reactive protein levels in patients with recent onset type 1 diabetes 22
Pain and Frailty in Hospitalized Older Adults 22
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 22
The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period 22
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 21
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 21
Liver cirrhosis after prolonged therapy with IFN-alpha plus IL-2 in a metastatic renal cancer long-term survivor 21
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 21
Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension 21
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 21
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 21
Totale 8.156
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022336 0 2 8 0 3 3 2 6 46 4 4 258
2022/2023112 12 1 6 4 10 2 30 4 3 5 33 2
2023/2024636 26 50 18 62 61 269 2 37 8 40 20 43
2024/20258.381 131 57 236 45 110 186 143 34 482 562 3.017 3.378
2025/2026161 161 0 0 0 0 0 0 0 0 0 0 0
Totale 9.626